MiddleBrook Pharmaceuticals just completed the hiring of a 271-person salesforce to start promoting MOXATAG on March 16, 2009. MOXATAG (extended-release amoxicillin) is the first and only FDA-approved once-daily amoxicillin.

Wow, it’s always nice to hear good news in bad times. Let’s see what CEO John Thievon had to say:

“We are delighted to have achieved another significant milestone in preparation for the launch of MOXATAG. About 135 territory managers have already completed our comprehensive training program, and the remaining territory managers will be fully trained in advance of our professional launch date of March 16, 2009. The territory managers who have completed our training program are in the field now with KEFLEX 750 mg patient starter samples talking to health care professionals about the advantages of our KEFLEX 750 mg product. Once we launch MOXATAG, all of our territory managers will detail MOXATAG and KEFLEX, and they will have MOXATAG patient starter samples as well.”

Good luck!!

Image from takingthestreet

Related Posts